TER-1754

N/A

Report date: 2026/04/14 20:00:15
NME

Base Information

Drug NameTER-1754
Drug Alias NameTER-1754
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase AKT1 inhibitors
TargetsSerine/threonine-protein kinase AKT1
Therapy Area/IndicationsTelangiectasia, Hereditary Hemorrhagic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTerremoto Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTerremoto Biosciences Inc
Active IndicationsN/A
Inactive IndicationsTelangiectasia, Hereditary Hemorrhagic

Other Information

ATC CodeN/A
Related LinksN/A